Filing Flows › Fractyl Health (GUTS) › Recalls, complaints & regulation
Fractyl Health (GUTS): clinical trials
Fractyl Health (GUTS) beyond its filings: 1 active clinical trial.
Fractyl Health's latest quarter
Fractyl Health, Q4 2024: revenue $3K (-57% year over year), net loss $25.0M, operating cash flow −$17.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Fractyl Health have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.